Evidence map›Paper›PMID 30937691›Full record

ArticleInvestigational new drugs2019

Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-

Jung Jin Hwang, Yong Sook Kim, Taelim Kim, Mi Joung Kim, In Gab Jeong, Je-Hwan Lee, Jene Choi, Sejin Jang, Seonggu Ro, Choung-Soo Kim

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Investigational new drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jung Jin HwangDepartment of Convergence Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 05505, South Korea.
Yong Sook KimInstitute for Innovative Cancer Research, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 05505, South Korea.
Taelim KimInstitute for Innovative Cancer Research, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 05505, South Korea.
Mi Joung KimInstitute for Innovative Cancer Research, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 05505, South Korea.
In Gab JeongDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, South Korea.
Je-Hwan LeeDepartment of Internal Medicine & Laboratory Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 05505, South Korea.
Jene ChoiDepartment of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 05505, South Korea.
Sejin JangDepartment of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 05505, South Korea.
Seonggu RoPiMedBio, Inc., Seoul, 06367, South Korea.
Choung-Soo KimDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, South Korea. cskim@amc.seoul.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The blots of control and docetaxel for caspase-9, caspase-3, caspase-8, Bcl-

Identifiers

PMID30937691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.